Warning message

Saint Luke's is now offering virtual visits with providers at this clinic. Call the clinic to schedule a virtual appointment.

Saint Luke's Mid America Heart Institute


Saint Luke’s Mid America Heart Institute offers the most comprehensive heart and vascular care in Kansas City. We provide the full range of cardiovascular services, from disease prevention to heart transplantation. At Saint Luke’s we use the latest technology to provide a full range of services and treatments. 

We provide:

  • More specialized physicians
  • More experience
  • More innovative treatment options for patients

Saint Luke’s Hospital is proud to be ranked in the top 50 in the nation for cardiology and heart surgery by U.S. News & World Report and is the third hospital in the U.S to achieve Comprehensive Cardiac Center certification from The Joint Commission.

Services

Research and Clinical Trials

Cardiovascular research continues to be a major focus at Saint Luke’s Health System. The program currently encompasses research programs in each of the major clinical areas, including interventional cardiology, cardiac surgery, heart failure and cardiac transplantation, cardiac electrophysiology, cardiac imaging, and preventive cardiology/lipid and diabetes management.

In addition to supporting clinical research, the cardiovascular research program encompasses centers of excellence and core laboratories in:

  • Cardiovascular outcomes research
  • Health economics and technology assessment
  • Intravascular imaging
  • Noninvasive imaging

These centers of excellence currently serve as core laboratories for a wide range of studies that often involve collaboration with other leading cardiovascular centers and researchers from around the world. MAHI continues to serve as one of the four Analytic Centers, along with Duke, Harvard, and Yale, for the American College of Cardiology’s National Cardiovascular Data Registry.

Saint Luke's Mid America Heart Institute

Saint Luke's Mid America Heart Institute

4401 Wornall Rd
Kansas City, MO 64111 

Saint Luke's News

Jun. 25, 2024

U.S. News & World Report: Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms

Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, new research led by Saint Luke's Mid America Heart Institute shows.
Jun. 25, 2024

Cardiovascular Business: Semaglutide Improves Heart Failure Symptoms in Both Sexes—Weight Loss Greater in Women

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.
May. 31, 2024

KSHB: Are Weight-Loss Drugs the Future of Medicine? Here's What KC-Area Experts Had to Say

KSHB talked to Dr. Mikhail Kosiborod about the significant impact of new weight-loss drugs for those who need it most.